Browsing Centre for Genomics and Child Health by Author "Burden, A"
Now showing items 1-8 of 8
-
Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size
Postma, DS; Kaplan, A; Soriano, JB; Grigg, J; Guilbert, TW; van Aalderen, W; Roche, N; Burden, A; Hillyer, EV; Israel, E (2017-06-01) -
Comparative effectiveness analysis: Extra-fine particle hydrofluoroalkane beclomethasone dipropionate vs fluticasone propionate with spacer in children
Grigg, J; van Aalderen, W; Israel, E; Colice, G; Martin, R; Dorinsky, P; Postma, D; Roche, N; Burden, A; Hillyer, E (2013-09-01) -
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
Postma, DS; Roche, N; Colice, G; Israel, E; Martin, RJ; van Aalderen, WMC; Grigg, J; Burden, A; Hillyer, EV; von Ziegenweidt, J (2014) -
Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
Martin, RJ; Price, D; Roche, N; Israel, E; van Aalderen, WMC; Grigg, J; Postma, DS; Guilbert, TW; Hillyer, EV; Burden, A (2014-10-09) -
Impact of age on extra-fine particle hydrofluoroalkane beclometasone dipropionate versus fluticasone propionate outcomes in asthmatic children
van Aalderen, W; Price, D; Colice, G; Dorinsky, P; Israel, E; Martin, R; Postma, D; Roche, N; Burden, A; Hillyer, E (2013-09-01) -
Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
Israel, E; Roche, N; Martin, RJ; Colice, G; Dorinsky, PM; Postma, DS; Guilbert, TW; van Aalderen, WMC; Grigg, J; Hillyer, EV (2015-06)RATIONALE: Guidelines advocate adding long-acting β-agonist (LABA) to inhaled corticosteroid as the preferred step-up therapy to increasing inhaled corticosteroid dose for patients with uncontrolled asthma on inhaled ... -
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
Israel, E; Colice, G; Grigg, J; Martin, R; van Aalderen, W; Dorinsky, P; Postma, D; Roche, N; Burden, A; von Ziegenweidt, J (2013-09-01) -
Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
Sonnappa, S; Martin, R; Israel, E; Postma, D; van Aalderen, W; Burden, A; Usmani, OS; Price, DB; Respiratory Effectiveness Group, Small Airways Study Group (2017)BACKGROUND: Regular use of inhaled corticosteroids (ICS) in patients with obstructive lung diseases has been associated with a higher risk of pneumonia, particularly in COPD. The risk of pneumonia has not been previously ...